Cargando…
CIN85 Deficiency Prevents Nephrin Endocytosis and Proteinuria in Diabetes
Diabetic nephropathy (DN) is the major cause of end-stage renal disease worldwide. Podocytes are important for glomerular filtration barrier function and maintenance of size selectivity in protein filtration in the kidney. Podocyte damage is the basis of many glomerular diseases characterized by los...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314701/ https://www.ncbi.nlm.nih.gov/pubmed/27531950 http://dx.doi.org/10.2337/db16-0081 |
_version_ | 1782508567242211328 |
---|---|
author | Teng, Beina Schroder, Patricia Müller-Deile, Janina Schenk, Heiko Staggs, Lynne Tossidou, Irini Dikic, Ivan Haller, Hermann Schiffer, Mario |
author_facet | Teng, Beina Schroder, Patricia Müller-Deile, Janina Schenk, Heiko Staggs, Lynne Tossidou, Irini Dikic, Ivan Haller, Hermann Schiffer, Mario |
author_sort | Teng, Beina |
collection | PubMed |
description | Diabetic nephropathy (DN) is the major cause of end-stage renal disease worldwide. Podocytes are important for glomerular filtration barrier function and maintenance of size selectivity in protein filtration in the kidney. Podocyte damage is the basis of many glomerular diseases characterized by loss of interdigitating foot processes and decreased expression of components of the slit diaphragm. Nephrin, a podocyte-specific protein, is the main component of the slit diaphragm. Loss of nephrin is observed in human and rodent models of diabetic kidney disease. The long isoform of CIN85 (RukL) is a binding partner of nephrin that mediates nephrin endocytosis via ubiquitination in podocytes. Here we demonstrate that the loss of nephrin expression and the onset of proteinuria in diabetic mice correlate with an increased accumulation of ubiquitinated proteins and expression of CIN85/RukL in podocytes. CIN85/RukL deficiency preserved nephrin surface expression on the slit diaphragm and reduced proteinuria in diabetic mice, whereas overexpression of CIN85 in zebrafish induced severe edema and disruption of the filtration barrier. Thus, CIN85/RukL is involved in endocytosis of nephrin in podocytes under diabetic conditions, causing podocyte depletion and promoting proteinuria. CIN85/RukL expression therefore shows potential to be a novel target for antiproteinuric therapy in diabetes. |
format | Online Article Text |
id | pubmed-5314701 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-53147012017-12-01 CIN85 Deficiency Prevents Nephrin Endocytosis and Proteinuria in Diabetes Teng, Beina Schroder, Patricia Müller-Deile, Janina Schenk, Heiko Staggs, Lynne Tossidou, Irini Dikic, Ivan Haller, Hermann Schiffer, Mario Diabetes Complications Diabetic nephropathy (DN) is the major cause of end-stage renal disease worldwide. Podocytes are important for glomerular filtration barrier function and maintenance of size selectivity in protein filtration in the kidney. Podocyte damage is the basis of many glomerular diseases characterized by loss of interdigitating foot processes and decreased expression of components of the slit diaphragm. Nephrin, a podocyte-specific protein, is the main component of the slit diaphragm. Loss of nephrin is observed in human and rodent models of diabetic kidney disease. The long isoform of CIN85 (RukL) is a binding partner of nephrin that mediates nephrin endocytosis via ubiquitination in podocytes. Here we demonstrate that the loss of nephrin expression and the onset of proteinuria in diabetic mice correlate with an increased accumulation of ubiquitinated proteins and expression of CIN85/RukL in podocytes. CIN85/RukL deficiency preserved nephrin surface expression on the slit diaphragm and reduced proteinuria in diabetic mice, whereas overexpression of CIN85 in zebrafish induced severe edema and disruption of the filtration barrier. Thus, CIN85/RukL is involved in endocytosis of nephrin in podocytes under diabetic conditions, causing podocyte depletion and promoting proteinuria. CIN85/RukL expression therefore shows potential to be a novel target for antiproteinuric therapy in diabetes. American Diabetes Association 2016-12 2016-08-16 /pmc/articles/PMC5314701/ /pubmed/27531950 http://dx.doi.org/10.2337/db16-0081 Text en © 2016 by the American Diabetes Association. http://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license. |
spellingShingle | Complications Teng, Beina Schroder, Patricia Müller-Deile, Janina Schenk, Heiko Staggs, Lynne Tossidou, Irini Dikic, Ivan Haller, Hermann Schiffer, Mario CIN85 Deficiency Prevents Nephrin Endocytosis and Proteinuria in Diabetes |
title | CIN85 Deficiency Prevents Nephrin Endocytosis and Proteinuria in Diabetes |
title_full | CIN85 Deficiency Prevents Nephrin Endocytosis and Proteinuria in Diabetes |
title_fullStr | CIN85 Deficiency Prevents Nephrin Endocytosis and Proteinuria in Diabetes |
title_full_unstemmed | CIN85 Deficiency Prevents Nephrin Endocytosis and Proteinuria in Diabetes |
title_short | CIN85 Deficiency Prevents Nephrin Endocytosis and Proteinuria in Diabetes |
title_sort | cin85 deficiency prevents nephrin endocytosis and proteinuria in diabetes |
topic | Complications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314701/ https://www.ncbi.nlm.nih.gov/pubmed/27531950 http://dx.doi.org/10.2337/db16-0081 |
work_keys_str_mv | AT tengbeina cin85deficiencypreventsnephrinendocytosisandproteinuriaindiabetes AT schroderpatricia cin85deficiencypreventsnephrinendocytosisandproteinuriaindiabetes AT mullerdeilejanina cin85deficiencypreventsnephrinendocytosisandproteinuriaindiabetes AT schenkheiko cin85deficiencypreventsnephrinendocytosisandproteinuriaindiabetes AT staggslynne cin85deficiencypreventsnephrinendocytosisandproteinuriaindiabetes AT tossidouirini cin85deficiencypreventsnephrinendocytosisandproteinuriaindiabetes AT dikicivan cin85deficiencypreventsnephrinendocytosisandproteinuriaindiabetes AT hallerhermann cin85deficiencypreventsnephrinendocytosisandproteinuriaindiabetes AT schiffermario cin85deficiencypreventsnephrinendocytosisandproteinuriaindiabetes |